ABEO Abeona Therapeutics
Abeona Therapeutics earnings company data as of 8:10 AM ET 11/16
- 1 of 2 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 9 Nov | EPS | -0.17 | -0.08 | Beat |
| Rev | — | $13.5M | — | ||
| FY2026 Q2 | 13 Aug | EPS | -0.25 | -0.35 | Miss |
| Rev | — | $11.4M | — |
Insider trades
Open-market buys and sales by ABEO's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $34K bought by 1 insider
- $259K sold by 2 insiders outside a trading plan
- $547K sold by 3 insiders under 10b5-1 plans
-
Faith L. Charles DirectorBuy$34K 15,000 shares at $2.29 +8.5% to stakeTraded Nov 13 Filed Nov 16
-
Mark Alvino DirectorSale$88K 15,000 shares at $5.86 20% of stakeTraded Sep 1 Filed Sep 1
-
Leila Alland DirectorSale$65K 11,000 shares at $5.92 6.3% of stakeTraded Jun 30 Filed Jul 2
-
Joseph Walter Vazzano CFOPlanned sale$138K 25,646 shares at $5.39 4.7% of stakeTraded Jun 9 Filed Jun 9
-
Mark Alvino DirectorSale$35K 6,500 shares at $5.46 7.7% of stakeTraded May 22 Filed May 22
-
Eric Crombez DirectorPlanned sale$145K 26,143 shares at $5.53 41% of stakeTraded May 15 Filed May 15
-
Vishwas Seshadri CEOPlanned sale$131K 29,985 shares at $4.38 2.1% of stakeTraded Mar 31 Filed Mar 31
-
Mark Alvino DirectorSale$71K 13,500 shares at $5.23 22% of stakeTraded Jan 21 Filed Jan 21
-
Vishwas Seshadri CEOPlanned sale$133K 25,000 shares at $5.31 2.1% of stakeTraded Dec 29, 2025 Filed Dec 29, 2025
-
Mark Alvino DirectorSale$71K 15,000 shares at $4.74 19% of stakeTraded Nov 13, 2025 Filed Nov 14, 2025
Also filed in the last 12 months, not counted as buying or selling: 29 sales to cover taxes, 13 stock grants, 1 gift, and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 19 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.01,3.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 424B3 | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon